EDAP reports record 2025 HIFU revenue up 39% YoY; net loss widens, FY2026 guidance reaffirmed

EDAP TMS SA

HIFU revenue €33.1M in FY2025, +39% YoY; Focal One placements up 69% YoY.
Q4 HIFU revenue €11.7M (+34% YoY); Q4 U.S. procedures grew 28% YoY.
Q4 net loss €8.2M (€0.22/share) vs €1.9M (€0.05/share) prior year; operating loss €5.2M.
Q4 gross margin 42.6%, down from 44.8%, due to tariffs and inventory reserve; adjusted ~46.9%.
Reaffirms FY2026 revenue guidance $72-80M; core HIFU $50-54M (34-45% YoY growth).

item 2.02 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.85

EDAP TMS SA updated its the fourth quarter and full-year 2025 guidance (reaffirmed).

Period: the fourth quarter and full-year 2025
Guidance: reaffirmed
Result: reported results

Exact text from the filing

On March 25, 2026, EDAP TMS S.A. issued a press release and will hold a conference call regarding its financial results for the quarter ended December 31, 2025.

View on SEC.gov

168 earnings releases filed in the last 30 days. Browse all earnings releases →

EDAP TMS SA filing history →

Source: SEC EDGAR

accession 0001171843-26-001889

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.